Skip to main content
ArticleOPEN ACCESS

Strontium ranelate: The first dual action bone agent

South African Family Practice
DOI: 10.1080/20786204.2006.10873409
0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

This edition of Medifile reviews a new drug, strontium ranelate. Protos® (strontium ranelate) is the first dual action bone agent registered for the treatment of postmenopausal osteoporosis to reduce the risk of vertebral and peripheral fractures, including the hip. © 2005 / Copyright reserved by MediKredit Integrated Healthcare Solutions (Pty) Ltd.

Cite

CITATION STYLE

APA

Chunder, R. (2006). Strontium ranelate: The first dual action bone agent. South African Family Practice. Medpharm Publications. https://doi.org/10.1080/20786204.2006.10873409

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free